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With 8-'C-styrene oxide as substrate, specific glutathione S-transferase and epoxide
hydrase activities were determined in subcellular fractions of liver, lungs, kidney, and
intestinal mucosa from rabbit, rat, and guinea pig. Liver had the highest enzyme activi-
ties in each species. Rat and guinea pig had higher glutathione S-transferase activity in
both liver and kidney than rabbit. Rat testis also had appreciable glutathione S-trans.
ferase activity.
The perinatal development of epoxide hydrase and glutathione S-transferase was
followed in liver and several extrahepatic tissues of fetal and neonatal guinea pigs and
rabbits. The rates at which enzyme activities reached adult levels in the extrahepatic
tissues differed from the liver in both species. Epoxide hydrase and glutathione S-trans-
ferases developed at different rates in each organ, demonstrating that the relative im-
portance of these two detoxifying pathways for styrene oxide may shift before and after
birth.
The effects of pretreating male and female rats with phenobarbital (PB), 1,2,3,4-
dibenzanthracene (DBA), pregnenolone-16a-carbonitrile (PCN), or 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD) on hepatic and extrahepatic epoxide hydrase and glutathione
S-transferase activities toward styrene oxide were determined. PB increased both enzyme
activities in liver of both sexes. PCN induced only glutathione S-transferase activity in
female liver. Extrahepatic epoxide hydrase and glutathione S-transferase activities were
unaffected except that TCDD doubled female renal epoxide hydrase activity and PB in-
creased intestinal epoxide hydrase activity in both sexes.
Styrene oxide biotransformation was studied in isolated, perfused rat liver and rabbit
lung preparations. Conjugation with glutathione was a major metabolic pathway although
significant amounts of diol were also formed in each instance. In rat liver, 27-40% of
the administered styrene oxide was excreted via the bile mainly as S-(1-phenyl-2-
hydroxyethyl)glutathione.
Introduction
The cytochrome P-450-dependent mixed-
function oxidase system found in the micro-
somal fraction of hepatic and, to a lesser ex-
tent, other tissues, is able to metabolize a wide
variety of endogenous and exogenous sub-
strates. Of particular importance is its ability
to oxidize olefins and aromatic hydrocarbons
to epoxides and arene oxides, respectively
(1, 2). These metabolites are chemically re-
active and, in fact, are covalently bound to
cellular macromolecules (3, 4). The binding of
arene oxides derived from polycyclic hydro-
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carbons to DNA appears to be a critical bio-
chemical event in carcinogenesis and muta-
genesis (5-7).
Styrene oxide, which is thought to be the
initial oxidative metabolite of styrene, is more
toxic than styrene in the rat (8); it has been
shown to be carcinogenic in mouse skin (9)
and is also mutagenic (10). It is, therefore, a
useful model compound for study of the de-
toxifying systems which remove the highly
electrophilic epoxides from body tissues.
Epoxides are metabolized principally by two
enzymatic systems. Microsomal expoxide hy-
drase (11) catalyzes the addition of water to
the expoxide ring to form a diol. Glutathione
S-transferases, a group of soluble enzymes
(12), convert epoxides to glutathione conju-
October 1976 135gates which are the precursors of urinary
mercapturic acids (13). Styrene oxide is a sub-
strate for both enzymes and is converted by
epoxide hydrase to styrene glycol and by
glutathione S-transferase to S-(1-phenyl-2 hy-
droxyethyl) glutathione (Fig. 1).
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FIGURE 1. Some potential metabolites of styrene oxide
(1) arising from initial hydration or conjugation
with glutathione. Metabolites illustrated are (2) sty-
rene glycol, (3) mandelic acid, (4) benzoic acid, (5)
S(1-phenyl-2-hydroxy-ethyl)glutathione, (6) S(1-
phenyl-2-hydroxyethyl)cysteinylglycine, (7) S(1-
phenyl-2-hydroxyethyl) cysteine, and (8) N-acetyl-
S(1-phenyl-2-hydroxyethyl) cysteine.
This paper summarizes some of our studies
on the in vitro metabolism of styrene oxide by
hepatic and extrahepatic subcellular fractions
from various rodent species and in isolated
perfused rabbit lung and rat liver preparations.
Tissue Distribution of Epoxide-Metabolizing
Enzymes
14C-Styrene oxide was used to determine the
tissue distribution of both glutathione S-trans-
ferase and epoxide hydrase in the guinea pig
and rabbit (14). Table 1 shows the data for
glutathione S-transferase activity. In all tissues
the guinea pig showed much higher specific
activities than the rabbit. Activity in guinea
pig skin was not determined. In both species,
liver and kidney extracts showed the highest
specific activities.
Table 1. Hepatic and extrahepatic glutathione
S-transferase activities in the guinea pig and
the rabbit.a
Glutathione conjugate formed,
nmole/min-mg proteinb
Tissue Rabbit Guinea pig
Liver 30.5 ± 1.6 (15) 236.5 !4.49.3 (9)
Lung 6.5 ± 0.6 (15) 18.6 ± 3.3 (9)
Kidney 7.9 ± 0.9 (15) 73.5 ± 10.6 (9)
Intestinal mucosa 4.4 + 0.4 (15) 24.6 ± 2.7 (9)
Skinc 0.7, 1.2
a Data from James, Fouts, and Bend (14).
b Mean + S.D. (N).
c Pohl and Bend, unpublished data.
Table 2 shows the results for the analysis of
epoxide hydrase activity in tissues of both
species. Except for kidney, guinea pigs show
higher activity in each tissue studied. Again,
both species showed highest activity in the
liver with the intestinal mucosa next.
Table 2. Hepatic and extrahepatic epoxide hydrase
activities in the guinea pig and the rabbit.a
Styrene glycol formed,
nmole/min-mg microsomal proteinb
Tissue Rabbit Guinea pig
Liver 5.6 ± 0.3 (15) 13.7 ± 3.1 (9)
Lung 0.17 ± 0.02 (15) 0.47 ± 0.12 (9)
Kidney 1.4 ± 0.1 (15) 1.1 ± 0.3 (9)
Intestinal mucosa 2.8 + 0.3 (15) 5.8 ± 1.1 (9)
Skinc 0.02, 0.02
a Data from James, Fouts, and Bend (14).
b Mean + S.D. (N).
e Pohl and Bend, unpublished data.
The low activity for both hydrase and gluta-
thione S-transferase in rabbit skin is interest-
ing. Styrene oxide has been shown to be car-
cinogenic to mouse skin (9). If, as seems likely,
only small amounts of the detoxifying enzymes
are present in this tissue, these would be easily
Environmental Health Perspectives 136saturated leaving the tissue with no defense
against the toxic action of the epoxide.
Table 3. Hepatic and extrahepatic glutathione
S-transferase activity in male and female rats
with styrene oxide as substrate.
GSH conjugate formed,
nmole/min-mg protein a
Tissue Male Female
Liver 197.9 ± 15.9 123.7 ± 5.6b
Lung 19.5 ± 3.3 20.0 ± 1.7
Kidney 114.7 ± 19.2 105.9 ± 13.8
Intestinal mucosa 14.5 ± 1.5 14.9 ± 2.5
Testis 91.2 ± 3.5
aMean + S.D. (N=3).
b p < 0.01, male vs. female (two-sided Students' t test).
Similar studies have been carried out com-
paring the distribution of these two enzyme
systems in the tissues of male and female adult
rats. Table 3 summarizes the glutathione S-
transferase activities. The results clearly show
a sex difference in hepatic activities, with livers
from female animals showing about 60% of
the activity found in male tissues. Other tissues
common to both sexes displayed comparable
activities with a relative order similar to rabbit
and guinea pig (Table 1).
Table 4. Hepatic and extrahepatic epoxide hydrase
activity in male and female rats with styrene
oxide as substrate.
Styrene glycol formed,
nmole/min-mg microsomal proteina
Tissue Male Female
Liver 5.25 ± 0.72 4.94 + 0.60
Lung 0.77 ± 0.13 0.37 ± 0.09
Kidney 1.30 ± 0.21 1.15 ± 0.34
Intestinal mucosa 0.35 ± 0.09 0.38 ± 0.02
Testis 2.10 ± 0.31
aMean +S.D. (N=3).
Epoxide hydrase does not show any statisti-
cally significant sex difference in activity in
any tissue except lung. In tissues common to
both sexes, highest activity was found in the
liver and lowest activity in the intestinal
mucosa (Table 4).
Two points of interest arise from the data in
Tables 3 and 4. First, both male and female
rats have relatively low activities of both
epoxide-metabolizing systems in the lung. This
limits the ability of the lung to detoxify epox-
ides, and, consequently, it may be an important
factor in the formation of pulmonary tumors
after the administration of certain polycyclic
hydrocarbons.
The second point concerns the relatively high
glutathione S-transferase and epoxide hydrase
activities in testes. The presence of large
amounts of epoxide-detoxifying enzymes in re-
productive tissue may well be an important
defense mechanism against chemical mutagens.
Perinatal Development of
Epoxide-Metabolozing Enzymes
The ability of neonatal tissues to detoxify
epoxides and other reactive toxicants is a topic
of considerable importance. Animals before and
shortly after birth are often deficient in drug-
metabolizing enzymes (15). The development
of the enzyme systems which are responsible
for xenobiotic transformation is a major con-
cern in our laboratories since neonates may be
especially sensitive to chemical toxicity.
We have examined the development of micro-
somal expoxide hydrase and cytosolic gluta-
thione S-transferase (with styrene oxide as
substrate) in hepatic and extrahepatic tissues
of both the rabbit and guinea pig (15, 16). Age-
related alterations in rabbit pulmonary gluta-
thione S-transferase activity toward styrene
xodie (labeled epoxide transferase) and 1,2-
dichloro-4-nitrobenzene (labeled aryl trans-
ferase) are shown in Figure 2. At the earliest
time point at which sufficient tissue was avail-
able for assay, specific activities were already
greater than 50% adult levels. The apparent
decrease in specific activity near birth ap-
peared to be due to the synthesis of cytosolic
protein which did not have glutathione S-trans-
ferase activity since there was no concomitant
decrease in whole tissue activity. In contrast,
the development of transferase activity oc-
curred substantially more slowly in liver (Fig.
3). In hepatic tissue, activity was very low
until after birth, and at 30 days of age liver
specific activity was still only about 50% adult
levels (with styrene oxide as substrate). These
data are representative of those observed in
the various organs with both glutathione S-
transferase and epoxide hydrase. Thus, the
rates at which adult activities are reached in
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FIGURE 2. Perinatal development of glutathione S-trans-
ferase activity toward styrene oxide (labeled epoxide
transferase) and 1,2-dichloro-4-nitrobenzene (labeled
aryl transferase) in 176,000 g supernatant fraction of
rabbit lung homogenates. Data are expressed a mean
-4- S.D._ N = 3 litters (up to 33 days of age; tissues
from one litter pooled prior to homogenization) or 3
individuals (80 days of age and older, all males).
extrahepatic tissues differ from liver for both
rabbits and guinea pigs. Moreover, epoxide
hydrase and glutathione S-transferase activi-
ties develop with age at different rates in any
single organ. Thus, the balance in epoxide
metabolism by hydration or by conjugation
with glutathione shifts in vitro before and
after birth and these alterations could be im-
portant in epoxide-medicated toxicity (terato-
genesis, carcinogenesis) to fetal or neonatal
tissues.
With discovery of the relatively high gluta-
thione S-transferase and epoxide hydrase activ-
ities in the testes of rats (Tables 3 and 4), we
cecided to compare the development of these
two styrene oxide detoxifying systems in this
germinal tissue to that of liver (G. L. Foure-
man, I. P. Lee, and J. R. Bend, unpublished
data). At the earliest time point at which suffi-
cient testis could be obtained for assay (7 days,
Table 5), appreciable glutathione S-transferase
activity (> 50 nmole/min-mg protein) was ob-
served. The time course of the specific trans-
ferase activity showed an apparent decline
from 20 to 45 days after birth and then a
steady increase up to about 200 days. However,
a steady increase in total enzyme activity was
observed with age up to about 50 days of age,
at which time near-adult levels were reached
(Table 5).
Similar studies with microsomal epoxide
hydrase (Table 6) demonstrated that testis had
low activity until about 30 days postpartum.
Thereafter, activity increased rapidly until
adult levels were reached by 45-50 days of age.
The slower development of epoxide hydrase
activity in testis could potentially be impor-
tant, for example, if an immature animal were
exposed to a toxic epoxide that was a good sub-
strate for epoxide hydrase but a poor substrate
for the glutathione S-transferases. Such com-
pounds are known. Thus, the carcinogen cho-
lesterol-5a,6a-epoxide is hydrated by microso-
mal epoxide hydrase (17, 18) but is not a sub-
strate for the glutathione transferases (A. J.
Ryan, Z. Ben-Zvi, and J. R. Bend, unpublished
observations).
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FIGURE 3. Perinatal development of glutathione S-trans-
ferase activity towards styrene oxide (labeled epoxide
transferase) and 1,2-dichloro-4-nitrobenzene (labeled
aryl transferase) in 176,000g supernatant fraction of
rabbit liver homogenates. D)ata are mean ± S.D. as
d
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138Table 5. Development of glutathione S-transferase activity in liver and testis of guinea pig.
Liver Testis
Age, Specific Total Specific Total
days activity activity activity activity
post partum nmole/min-mga nmole/minb nmole/min-mga nmole/minb
7 27.5 +5.4 986-1443 65.9 47.5-57.6
16 30.1 ±1.9 2129-2299 83.7 10.7 370-373
21 57.5 7.3 6130-6486 81.0 8.5 511-634
26 97.8 ±21.1 16970-18600 66.0 4.3 794-878
29 128.0 ± 9.1 35530-40860 68.9 ± 5.4 1103-1241
41 171.6 ±21.7 86330-99920 74.9 ± 5.8 4556-4882
46 195.8 18.0 154820-169250 86.4 ±4.4 5310-5518
54 164.9 ±24.8 123520-134860 78.5 + 5.6 7125-7945
125C 242.0 2.7 214000-239600 104.6 3.2 11740-13370
165 208.0 22.7 349500-364300 136.4 20.3 12430-15481
208 185.9 ± 20.7 250400-291900 138.0 ± 18.4 10751-13731
a Specific activity expressed as nmole glutathione conjugate formed/min per milligram of soluble protein with
styrene oxide as substrate.
b Range of total activity expressed as nmole glutathione conjugate formed/min per organ with styrene oxide
as substrate.
e Animals considered adult at this point.
Table 6. Development of epoxide hydrase in liver and testis of rat.
Liver Testis
Age, Specific Total Specific Total
days activity activity activity activity
post partum nmole/min-mga nmole/minb nmole/min-mga nmole/minb
7 0.24 ± 0.03 1.86-1.98 0.06 0.006
16 0.41 ± 0.02 10.55-11.65 0.03 ± 0.01 0.02-0.03
21 2.87 ± 0.34 110.0-128.7 0.17 ± 0.01 0.16-0.30
26 10.80 1.22 573-605 0.19 ±0.04 0.41-0.46
29 11.38 ± 1.63 998-1136 0.50 0.05 1.10-1.19
41 12.26 ± 2.25 2068-2227 1.26 ± 0.20 11.52-12.26
46 11.48 ± 0.96 2893-3830 1.87 ± 0.15 16.76-17.12
54 11.90 ± 2.26 3277-3629 1.45 ± 0.43 17.0-28.24
125C 8.86 ± 0.41 2435-2886 1.59 ± 0.17 17.26-26.14
165 8.43 ± 1.68 3576-4454 1.83 ± 0.39 16.12-31.36
a Specific activity as nmole styrene glycol formed/min per milligram of microsomal protein (± standard devia-
tion) with styrene oxide as substrate.
b Range of total activity expressed as nmole styrene glycol formed/min per organ with styrene oxide as
substrate.
c Animals considered adult at this point.
The stimulation of xenobiotic metabolism by
pretreatment of animals with a large number
of chemical compounds is a well documented
phenomenon (19). Both hepatic epoxide hy-
drase (20) and glutathione S-transferase ac-
tivity (21) are induced in the rat in response
to phenobarbital administration. We have
studied the effects of administering phenobarbi-
tal (PB), 1,2,3,4-dibenzanthracene (DBA),
pregnenolone-16a-carbonitrile (PCN), and 2,3,
7,8-tetrachlorodibenzo-p-dioxin (TCDD), com-
pounds which are known to induce the micro-
somal mixed-function oxidase system in rats,
on hepatic and extrahepatic (lung, kidney,
small intestinal mucosa, and testis) epoxide
hydrase and glutathione S-transferase activi-
ties in male and female rats. Styrene oxide was
used as the epoxide substrate. The xenobiotic
October 1976pretreatments had almost no effect on epoxide-
metabolizing enzyme activities in the extra-
hepatic tissues, except that epoxide hydrase
activity was increased in small intestine of
both male and female rats following pheno-
barbital treatment and renal epoxide hydrase
doubled in female rats, but not in male rats,
following TCDD administration.
Table 8. Effect of pretreatment of male rats on
hepatic 176,000g supernatant glutathione S-
transferase activity.a
Glutathione S-transferase
activity, nmole GSH conjugate
formed/min-mg proteinb
Inducer Control Treated
Phenobarbital 186.5 ± 24.3 367.3 ± 4.8c
Dibenzanthracene 188.0 ± 36.7 180.1 + 16.4
Pregnenolone-16a-
carbonitrile 182.4 ± 8.7 194.0 ± 16.0
TCDD 146.4 + 16.1 210.1 ± 20.72
a Phenobarbital and dibenzanthracene were given at
80 mg/kg for 3 days; pregnenolone-16a-carbonitrile was
given at 20 mg/kg for 2 days; 2,3,6,7-tetrachlorodi-
benzo-p-dioxin was given once at 10 ,g/kg. All com-
pounds were given by IP injection. Enzyme fractions
were prepared 24 hr after the last dose, except with
TCDD, where males were sacrificed 6 days after TCDD
administration and females 10 days after treatment.
b Mean +S.D. (N = 3).
p < 0.01, control vs. treated.
Table 7. Effect of pretreatment of female rats on
hepatic 176,000g supernatant glutathione S-
transferase activity.a
Glutathione S-transferase
activity, nmole GSH conjugate
formed/min-mg proteinb
Inducer Control Treated
Phenobarbital 118.3 ± 20.2 164.7 ± 19.0
Dibenzanthracene 122.8 ± 4.6 112.5 ± 35.0
Pregnenolone-16a-
carbonitrile 123.7 ± 5.6 158.3 ± 30.0
TCDD 121.6 ± 18.8 170.8 ± 25.6
a Phenobarbital and dibenzanthracene were given at
80 mg/kg for 3 days; pregnenolone-16a-carbonitrile was
given at 20 mg/kg for 2 days; 2,3,6,7-tetrachlorodi-
benzo-p-dioxin was given once at 10 pg/kg. All com-
pounds were given by IP injection. Enzyme fractions
were prepared 24 hr after the last dose, except with
TCDD, where males were sacrificed 6 days after TCDD
administration and females 10 days after treatment.
b Mean ±S.D. (N =3).
e p < 0.01, control vs. treated.
The hepatic enzyme activities from female
and male rats treated with the various xeno-
biotics are outlined in Tables 7-11. DBA failed
to increase glutathione S-transferase activity,
but significant increases in specific activity
were observed with PB, PCN, and TCDD in
females (Table 7). In male rats (Table 8), PB
and TCDD also increased transferase activity
toward styrene oxide, but PCN and DBA did
not increase enzyme activity. In the case of
PCN, this parallels its activity as an inducer
of microsomal mixed-function oxidase activity
in female, but does not in male, rats (19).
There is some variability in the induction of
glutathione transferase in male rat liver by
PB. Table 9 shows the extent of induction in
three groups of rats treated under identical
conditions. In each experiment statistically sig-
nificant increases in the specific activity of the
enzyme were obtained. The relative increases,
however, varied markedly between experi-
ments. Currently, we have no explanation for
this behavior.
Of the various compounds tested, only PB
caused substantial induction of hepatic micro-
somal epoxide hydrase in female rats (Table
10). PCN and TCDD tended to increase spe-
cific activity, but the effect was not statistically
significant for TCDD. Male rats (Table 11)
gave results essentially identical to those ob-
tained with females.
The data obtained allow a few conclusions
to be drawn. Thus, PB pretreatment increased
both epoxide metabolizing enzymes in both
sexes, whereas the polycyclic aromatic hydro-
carbon tested (DBA) did not affect either en-
zyme. It was especially interesting that TCDD
Table 9. Effect of phenobarbital pretreatment on
glutathione S-transferase activity of male rat
liver 176,000g supernatant fraction.a
Specific activity, nmole GSH
conjugate formed/min-mg proteinb
Induction,
Trial Control Treated %
A 186.5 ±24.3(3) 367.3 ±4.8(3) 100
B 214.0 ± 36.3(3) 347.6 ± 10.5(3) 60
C 186.9 ±15.5(4) 234.4 ±20.0(4) 30
a Rats were treated (IP) with 80 mg/kg Na pheno-
barbital in saline once daily for 3 consecutive days.
Animals were sacrificed 24 hr after the last injection.
b Mean + SD (N).
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hepatic microsomal epoxide hydrase activity.a
Epoxide hydrase activity, nmole
styrene glycol formed/min-mg
microsomal proteinb
Inducer Control Treated
Phenobarbital 4.50 ± 1.1 14.0 ± 1.6c
Dibenzanthracene 5.08 ± 1.14 5.60 ± 2.0
Pregnenolone-16a-
carbonitrile 5.22 ± 1.1 7.80 ± 2.2d
TCDD 4.94 ± 0.6 7.60 ± 1.8
a Phenobarbital and dibenzanthracene were given at
80 mg/kg for 3 days; pregn'enolone-16a-carbonitrile
was given at 20 mg/kg for 2 days; 2,3,6,7-tetrachloro-
dibenzo-p-dioxin was given once at 10Ag/kg, All com-
pounds were given by IP injection. Enzyme fractions
were prepared 24 hr after the last dose, except with
TCDD, where males were sacrificed 6 days after TCDD
administration and females 10 days after treatment.
b Mean + S.D. (N = 3).
cp <0.01, control vs. treated.
d p < 0.05, control vs. treated.
Table 11. Effect of pretreatment of male rats on hepatic
microsomal epoxide hydrase activity.a
Epoxide hydrase activity, nmole
styrene glycol formed/min-mg
proteinb
Inducer Control Treated
Phenobarbital 5.46 ± 1.04 13.94 ± 0.50 c
Dibenzanthracene 5.68 ± 1.13 6.30 ± 0.54
Pregnenolone-16a-
carbonitrile 4.78 ± 0.43 5.29 ± 0.25
TCDD 6.14 ± 2.00 6.85 ± 0.99
a Phenobarbital and dibenzanthracene were given at
80 mg/kg for 3 days; pregnenolone-16a-carbonitrile
was given at 20 mg/kg for 2 days; 2,3,6,7-tetrachloro-
dibenzo-p-dioxin was given once at lOpg/kg, All com-
pounds were given by IP injection. Enzyme fractions
were prepared 24 hr after the last dose, except with
TCDD, where males were sacrificed 6 days after TCDD
administration and females 10 days after treatment.
bMean + S.D. (N=3).
c p < 0.01, control vs. treated.
d p < 0.05, control vs. treated.
induced the transferase in both males and fe-
males without appreciably affecting the epoxide
hydrase in males, although there was an ap-
parent increase in females. The role that in-
duction of epoxide biotransformation pathways
plays in toxication-detoxication mechanisms
for epoxide precursors is obviously a matter
of speculation, especially since the rate at
which these oxirane metabolites are formed
from the hydrocarbons is also influenced by
these same inducing agents. However, it is a
problem that should be clarified, at least with
a few substrates.
Metabolism of Styrene Oxide in
Isolated Perfused Organs
The question of the relative importance of
epoxide hydrase and glutathione S-transferases
in the metabolism of epoxides is difficult to an-
swer from in vitro studies. The enzymes have
different subcellular locations. Epoxide hydrase
is bound to the endoplasmic reticulum and the
glutathione S-transferases are soluble com-
ponents in the cytoplasm. It requires the use of
preparations with intact cellular structure to
evaluate the two pathways for epoxide or arene
oxide metabolism. For these reasons the metab-
olism of 8-14C-styrene oxide was studied in iso-
lated organs. Two organs have been used, the
isolated perfused rat liver and the isolated
perfused rabbit lung. The rat liver preparation
is particularly advantageous since glutathione
conjugates are preferentially excreted in the
bile and are automatically separated from other
metabolites in the circulating perfusate.
Table 12. Excretion of radioactivity by isolated perfused
liver after treatment with styrene oxide-8-14C.
Dose in bile, Dose inperfusate,
Experiment % %
k 38.6 39.7
2 27.5 69.0
3 40.4 47.7
Table 13. Reverse isotope dilution analysis of metabo-
lites from styrene oxide-14C-treated isolated perfused
rat liver.
Radioactivity in fraction, % of total
Glutathione MandelLk Styrene
conjugate acid glycol
XAD-2 extract
of perfusate 21.6, 22.3 31.0, 32.7 35.1,43.1
Bile 91.6
At a dose of 0.1 mmole, 8-14C-styrene oxide
was rapidly excreted in the bile (Table 12). In
October 1976 141three experiments, between 30 and 40% of the
radioactivity was excreted by this pathway in
90 min. The remainder of the radioactivity was
found mainly in the perfusate. Examination of
the bile by TLC (Fig. 4) showed only one radio-
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FIGURE 4. Radioactivity scan of a thin-layer chromato-
gram of bile from rat liver perfused with '4C-styrene
oxide (100 /Amole). Developed in n-butanol-glacial
acetic acid-water (4:1:1).
active component present which was ninhydrin-
positive and cochromatographed with syn-
thetic S-(1-phenyl-2-hydroxethyl) glutathione
(Fig. 1). Reserve isotope dilution analysis of
the bile with the authentic conjugate (Table
13) confirmed that the glutathione derivative
was the only metabolite excreted in the bile.
Fractionation of the perfusate radioactivity
by means of XAD-2 resin and TLC indicated
that this probably consisted of styrene glycol,
mandelic acid, and the glutathione conjugate
(Fig. 5) (22). Reverse isotope dilution studies
(Table 13) confirmed the presence of approxi-
mately equal amounts of styrene oxide, man-
delic acid, and S-(1-phenyl-2-hydroxyethyl)
glutathione. Since mandelic acid is an oxidation
product of styrene glycol, the data indicate that
both hydration and conjugation with gluta-
thione are major metabolic pathways for sty-
rene oxide in the perfused liver at this epoxide
concentration, although thioether metabolites
may predominate slightly.
Recent reports have demonstrated that sty-
rene oxide is mutagenic (10). Because of this,
the covalent binding of styrene oxide to liver
protein was assayed. However, no significant
binding was detected in the livers used in these
experiments.
Similar experiments were carried out in an
isolated perfused rabbit lung preparation.
Lungs were removed from heparinized New
Zealand rabbits weighing 2-3 kg. At a styrene
oxide concentration of 80 /Amole styrene oxide/
lung various times after addition of epoxide
to the recirculating perfusate, aliquots were
removed and analyzed for metabolite formation.
Metabolite formation was linear for at least
45 min for both ethyl acetate-extractable (sty-
rene glycol) and water-soluble metabolites.
[Since ethyl acetate extraction was done at pH
7.4, these metabolites included S-(1-phenyl-2-
hydroxyethyl)glutathione, S-(1-phenyl-2-hy-
droxyethyl)cysteinylyglycine, and mandelic
acid. It is possible that N-acetyl-S-(1-phenyl-2-
hydroxyethyl)cysteine is also present, but this
has not been verified.] The water-soluble met-
abolites predominated in both the perfusate
and in the lung (at the end of the experiment).
However, both conjugation with glutathione
and hydration were major metabolic pathways
in lung. Shortly after perfusion was initiated (a
few minutes), the glutathione conjugate was
the only thioether metabolite present in lung.
However, substantial amounts of the cysteinyl-
glycine derivative were present in lung after
60 min. The glutathione conjugate serves as
Styrene
glycol
CD
Mandetic Glutathione
acid conjugate
CC <.::
Solvent
front
Starting
line
FIGURE 5. Radioactivity scan of a TLC plate of an
XAD-2 resin extract of the perfusate from a rat
liver treated with 14C-styrene oxide (100 Amole).
Plate developed in n-butanol-ethanol-concentrated
ammonia-water (4:1:1:1). Positions of styrene gly-
col, mandelic acid, and S(1-phenyl-2-hydroxyethyl)
glutathione on the same TLC plate are also shown.
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tive (Fig. 1), and the enzyme y-glutamyltrans-
peptidase catalyzes the conversion. As in the
liver, no evidence for covalent binding of the
radioactivity associated with styrene oxide to
lung protein was found under these conditions.
It is clear that in the two organs most likely
to be concerned with styrene oxide metabolism,
the liver and lung, both glutathione S-trans-
ferases and epoxide hydrase play a major role.
Studies in these organs with other epoxides and
arene oxides can be expected to provide useful
insights into the qualitative and quantitative
aspects of their metabolism by these two sys-
tems and how this alters epoxide toxicity.
Concluding Remarks
Epoxide-mediated target organ toxicity is
likely to be dependent on many factors. These
include the site and rate of absorption into the
body; the relative rates of hepatic and extra-
hepatic microsomal mixed-function oxidase
catalyzed epoxide formation from precursors;
the stability of the epoxide in the blood and the
rate of blood supply to the target organ; the
rate of uptake of the epoxide from the circu-
lation by tissues; and the relative abilities of
tissues to detoxify electrophilic epoxides after
entry into the cell. The present paper has at-
tempted to summarize the work of this labora-
tory in this last area, the assessment of the
ability of hepatic and extrahepatic tissues to
detoxify epoxides.
We are grateful to Dr. James R. Fouts for his con-
tinued encouragement and interest in this work, to Mr.
Gary Foureman who provided excellent technical assist-
ance for much of it and to Dr. Joseph Haseman who
conducted the statistical analyses.
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